Regencell Bioscience Holdings Limited reported a net loss of $11.7M in fiscal year 2026. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 8 fiscal years, from 2019 to 2026.
Annual figures, oldest first. Point at a bar to read its period.
RGC Net Income by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Regencell Bioscience Holdings Limited financials
Frequently Asked Questions
Regencell Bioscience Holdings Limited reported a net loss of $11.7M in fiscal year 2026.
Regencell Bioscience Holdings Limited (RGC) reported a $3.6M net loss in fiscal year 2025 and a $11.7M net loss in fiscal year 2026. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Across the 8 fiscal years this page covers, Regencell Bioscience Holdings Limited (RGC) net income went from -$391K in fiscal year 2019 to -$11.7M in fiscal year 2026.
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Regencell Bioscience Holdings Limited (RGC) reported on that line in every period on record.